Diabetes Research and Clinical Practice 2014; 105(3): 273-84., Brändle M, Trevisan R, Orsini Federici M, Liabat S, . Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes.
Journal of Medical Economics 2014; 17(12): 827-36., Lian J, Karolicki B, . The cost-effectiveness and budget impact of stepwise addition of bolus insulin in the treatment of type 2 diabetes: evaluation of the FullSTEP trial.
Muduma G, Odeyemi I, Journal of Medical Economics 2014; 17(7): 520-6.. A UK analysis of the cost of switching renal transplant patients from an immediate-release to a prolonged-release formulation of tacrolimus based on differences in trough concentration variability.
Giorda CB, Nicolucci A, Pellegrini F, Kristiansen CK, Diabetic Medicine 2014; 31(5): 615-23., , Vespasiani G. Improving quality of care in people with Type 2 diabetes through the Associazione Medici Diabetologi-annals initiative: a long-term cost-effectiveness analysis.
Muduma G, Odeyemi I, Patient Preference and Adherence 2014; 8: 391-9., . Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence.
Current Medical Research and Opinion 2014; 30(2): 235-42., Kalsekar A, . Influence of renal function on long-term graft survival and patient survival in renal transplant recipients.